Search research articles
Contact Us
Filters
Showing results (231-240 of 265) with videos related to
Page
of 27
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 13, 2022
Home-measured pulse pressure is a predictor of cardiovascular disease in type 2 diabetes: The KAMOGAWA-HBP study
Maya Takegami, Emi Ushigome, Shinnosuke Hata, et al.
Experimental Cell Research
|
December 11, 2020
Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis
Minoru Inomata, Koichiro Kamio, Arata Azuma, et al.
Thoracic Cancer
|
February 26, 2020
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancer
Teppei Sugano, Masahiro Seike, Yoshinobu Saito, et al.
Respiratory Medicine Case Reports
|
February 7, 2019
Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations
Junichi Aoyama, Hiroki Hayashi, Chika Yajima, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 31, 2008
The alpha-glucosidase inhibitor acarbose reduces the net electronegative charge of low-density lipoprotein in patients with newly diagnosed type 2 diabetes
Goji Hasegawa, Shizuo Kajiyama, Toru Tanaka, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 15, 2022
Impact of sustained hypertension on new cardiovascular events in patients with type 2 diabetes: KAMOGAWA-HBP study
Takashi Yoshimura, Emi Ushigome, Shinnosuke Hata, et al.
Journal of Hypertension
|
August 19, 2022
Maximum home blood pressure and cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study
Shinnosuke Hata, Emi Ushigome, Takashi Yoshimura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
January 11, 2023
Impact of continued high blood pressure on the progression of diabetic nephropathy after 10 years: KAMOGAWA-HBP study
Shinnosuke Hata, Emi Ushigome, Yukako Hosomi, et al.
Oxford Medical Case Reports
|
October 27, 2018
Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis
Takehiro Tozuka, Teppei Sugano, Rintaro Noro, et al.
Journal of Diabetes Investigation
|
March 19, 2019
Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA-HBP study
Takuro Okamura, Emi Ushigome, Nobuko Kitagawa, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 265) with videos related to
Sort By:
Page
of 27
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
September 13, 2022
Home-measured pulse pressure is a predictor of cardiovascular disease in type 2 diabetes: The KAMOGAWA-HBP study
Maya Takegami, Emi Ushigome, Shinnosuke Hata, et al.
Experimental Cell Research
|
December 11, 2020
Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axis
Minoru Inomata, Koichiro Kamio, Arata Azuma, et al.
Thoracic Cancer
|
February 26, 2020
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancer
Teppei Sugano, Masahiro Seike, Yoshinobu Saito, et al.
Respiratory Medicine Case Reports
|
February 7, 2019
Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations
Junichi Aoyama, Hiroki Hayashi, Chika Yajima, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
January 31, 2008
The alpha-glucosidase inhibitor acarbose reduces the net electronegative charge of low-density lipoprotein in patients with newly diagnosed type 2 diabetes
Goji Hasegawa, Shizuo Kajiyama, Toru Tanaka, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
November 15, 2022
Impact of sustained hypertension on new cardiovascular events in patients with type 2 diabetes: KAMOGAWA-HBP study
Takashi Yoshimura, Emi Ushigome, Shinnosuke Hata, et al.
Journal of Hypertension
|
August 19, 2022
Maximum home blood pressure and cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study
Shinnosuke Hata, Emi Ushigome, Takashi Yoshimura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension
|
January 11, 2023
Impact of continued high blood pressure on the progression of diabetic nephropathy after 10 years: KAMOGAWA-HBP study
Shinnosuke Hata, Emi Ushigome, Yukako Hosomi, et al.
Oxford Medical Case Reports
|
October 27, 2018
Pembrolizumab-induced agranulocytosis in a pulmonary pleomorphic carcinoma patient who developed interstitial lung disease and ocular myasthenia gravis
Takehiro Tozuka, Teppei Sugano, Rintaro Noro, et al.
Journal of Diabetes Investigation
|
March 19, 2019
Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA-HBP study
Takuro Okamura, Emi Ushigome, Nobuko Kitagawa, et al.
Page
of 27